lobbying_activities: 2957599

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2957599	3d3cb78b-2833-4844-a62f-b548d577d887	Q1	AMERICAN VETERINARY MEDICAL ASSOCIATION	3630	AMERICAN VETERINARY MEDICAL ASSOCIATION	2023	first_quarter	PHA	Compounding Guidance (GFI 256) H.R. 1418 Animal Drug User Fee Act/ Animal Generic Drug User Fee Act reauthorization H.R. 1839/S. 993 Combatting Illicit Xylazine Act	Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		330000	0	0	2023-04-12T10:49:30-04:00